Fabhalta Capsules Specified Drug-use Survey
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan
- Status
- COMPLETED
- Phase
- N/A
Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Real-world Outcomes Among Patients Treated With Ribociclib
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients
- Status
- RECRUITING
- Phase
- N/A
A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- Status
- RECRUITING
- Phase
- PHASE2
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- N/A
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of Real-World Outcomes of Ribociclib in First-Line Treatment for Metastatic HR+/HER2- Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
An Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab
- Status
- RECRUITING
- Phase
- PHASE2